Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.
In the absence of three-dimensional (3D) structures of potential drug targets, ligand-based drug design is one of the popular approaches for drug discovery and lead optimization. 3D structure-activity relationships (3D QSAR) and pharmacophore modeling are the most important and widely used tools in ligand-based drug design that can provide crucial insights into the nature of the interactions between drug target and ligand molecule and provide predictive models suitable for lead compound optimization. This review article will briefly discuss the features and potential application of recent advances in ligand-based drug design, with emphasis on a detailed description of a novel 3D QSAR method based on the conformationally sample pharmacophore (CSP) approach (denoted CSP-SAR). In addition, data from a published study are used to compare the CSP-SAR approach to the Catalyst method, emphasizing the utility of the CSP approach for ligand-based model development.
Acharya
Chayan
C
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA.
Coop
Andrew
A
Polli
James E
JE
Mackerell
Alexander D
AD
D017076:Computer-Aided Design; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D021281:Quantitative Structure-Activity Relationship
D008024:Ligands
Curr Top Med Chem. 2002 Dec;2(12):1381-94
12470286
J Comput Chem. 2004 Oct;25(13):1584-604
15264253
J Chem Inf Comput Sci. 2000 Jan;40(1):185-94
10661566
Science. 1995 Feb 3;267(5198):664-6
17745843
Biointerphases. 2008 Sep;3(3):FC2-12
19809597
Pharm Res. 2009 Jul;26(7):1665-78
19384469
J Mol Graph Model. 2004 Jul;22(6):499-505
15182809
Neoplasia. 2003 Sep-Oct;5(5):445-56
14670182
Adv Drug Deliv Rev. 2006 Nov 30;58(12-13):1431-50
17097188
Curr Opin Struct Biol. 2000 Aug;10(4):401-4
10981625
J Med Chem. 1994 Nov 25;37(24):4130-46
7990113
J Comput Chem. 2003 Nov 15;24(14):1691-702
12964188
J Am Chem Soc. 2007 May 16;129(19):6263-8
17441722
Curr Pharm Des. 2003;9(20):1649-64
12871063
J Chem Inf Comput Sci. 2000 Nov-Dec;40(6):1423-30
11128101
Clin Chem. 2004 Mar;50(3):490-9
14726470
J Comput Chem. 2010 Mar;31(4):671-90
19575467
Curr Opin Cell Biol. 1996 Oct;8(5):632-40
8939662
Mol Pharm. 2004 Jan 12;1(1):40-8
15832499
Biophys J. 2003 Nov;85(5):2900-18
14581194
Pharm Res. 1993 Apr;10(4):475-86
8483829
Bioorg Med Chem. 1995 Apr;3(4):411-28
8581425
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):251-72
11274894
Curr Med Chem. 2001 Jul;8(9):1035-55
11472240
J Biomed Sci. 1999 Jul-Aug;6(4):236-50
10420081
J Chem Inf Comput Sci. 2003 Jul-Aug;43(4):1200-7
12870912
Bioorg Med Chem. 2006 Jun 15;14(12):4137-50
16504515
J Med Chem. 1994 Oct 28;37(22):3758-67
7966135
Science. 1999 Feb 12;283(5404):990-3
9974393
J Mol Model. 2006 Jan;12(2):168-81
16205958
J Am Stat Assoc. 1949 Sep;44(247):335-41
18139350
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):674-9
12653537
J Comput Chem. 2008 Apr 30;29(6):965-82
17999384
J Am Chem Soc. 1988 Mar 1;110(6):1657-66
27557051
Adv Drug Deliv Rev. 2002 Mar 31;54(3):367-83
11922953
J Am Chem Soc. 1988 Aug 1;110(18):5959-67
22148765
Curr Top Med Chem. 2007;7(1):63-82
17266596
Bioorg Med Chem Lett. 2006 Dec 15;16(24):6281-7
17000106
J Comput Aided Mol Des. 1999 Jan;13(1):1-10
10087495
J Pharmacol Exp Ther. 2006 Sep;318(3):1273-9
16766719
J Med Chem. 1964 Jul;7:395-9
14221113
Science. 2000 Aug 4;289(5480):739-45
10926528
J Comput Chem. 2009 Jul 30;30(10):1545-614
19444816
Curr Med Chem. 2009;16(26):3381-413
19515013
J Med Chem. 2007 Apr 19;50(8):1799-809
17367120
Nat Rev Neurosci. 2003 Jan;4(1):13-25
12511858
J Comput Aided Mol Des. 1998 Jul;12(4):383-96
9777496
J Chem Inf Comput Sci. 2000 Jan-Feb;40(1):147-54
10661561
Bioorg Med Chem. 2007 Jan 15;15(2):1146-59
17127069
Nat Rev Drug Discov. 2003 Mar;2(3):192-204
12612645
Arch Pharm (Weinheim). 1998 Jul-Aug;331(7-8):233-40
9747179
J Chem Inf Model. 2008 Sep;48(9):1773-91
18763758
Endocrinology. 1997 Mar;138(3):863-70
9048584
J Am Chem Soc. 2003 Mar 12;125(10):3101-7
12617677
Nature. 2000 Oct 26;407(6807):971-7
11069170
Curr Pharm Des. 2001 May;7(7):567-97
11375769
J Am Chem Soc. 2005 Aug 10;127(31):10967-76
16076203
J Chem Inf Model. 2009 Apr;49(4):853-64
19391630
J Chem Inf Comput Sci. 2001 Mar-Apr;41(2):233-45
11277704
Peptides. 2007 Dec;28(12):2435-513
17949854
Science. 1992 Aug 21;257(5073):1078-82
1509259
J Mol Graph Model. 2004 May;22(5):377-95
15099834
J Comput Chem. 2003 Aug;24(11):1348-56
12827676
Curr Pharm Des. 2003;9(22):1817-26
12871199
Chem Rev. 2009 Jan;109(1):213-35
19099450
Brief Bioinform. 2002 Mar;3(1):73-86
12002226
Drug Discov Today Technol. 2004 Dec;1(3):241-6
24981491
J Med Chem. 1999 Aug 12;42(16):3183-7
10447964
Pharm Res. 2002 Dec;19(12):1788-800
12523656
J Chem Inf Comput Sci. 2002 Jul-Aug;42(4):903-11
12132892
J Med Chem. 2004 May 6;47(10):2499-510
15115393
Annu Rev Pharmacol Toxicol. 1997;37:71-90
9131247
J Comb Chem. 1999 Jan;1(1):55-68
10746014
Mol Pharm. 2006 May-Jun;3(3):223-30
16749855
Annu Rev Phys Chem. 2000;51:129-52
11031278
Biopolymers. 2000-2001;56(4):275-91
11754341
J Med Chem. 2004 Jul 15;47(15):3765-76
15239655
Nat Rev Drug Discov. 2005 Mar;4(3):206-20
15729362
Cancer Res. 2004 Feb 1;64(3):910-9
14871820
SAR QSAR Environ Res. 2004 Aug;15(4):237-49
15370415
Eur J Pharm Sci. 2006 Apr;27(5):411-24
16274971
Bioorg Med Chem Lett. 1999 Jan 18;9(2):241-4
10021937
Biophys J. 2003 Feb;84(2 Pt 1):775-86
12547762
Biopolymers. 2001;60(2):96-123
11455545
J Med Chem. 1979 Oct;22(10):1238-44
513071
J Med Chem. 2005 Dec 1;48(24):7773-80
16302816
J Comput Aided Mol Des. 2000 Mar;14(3):265-75
10756481
Crit Rev Oncol Hematol. 1995 Mar;18(3):207-31
7695833